新闻中心
Your location:
Homepage
/
Development path

Industry News

2021
2021
2022-03-03
Completion of CL-1000 trial production
Accumulated sales of 200 units, sales reached 20 million
Started the development of molecular diagnostic instruments
Started R&D of CL-2000Plus
MORE
Completion of CL-1000 trial production
Accumulated sales of 200 units, sales reached 20 million
Started the development of molecular diagnostic instruments
Started R&D of CL-2000Plus
2020
2020
2022-03-03
Added 15 new reagent items and research and development of CL-1000 automatic luminescence analyzer
2020.7 Received 30 million + Pre-A round of financing
2020.9 Obtained four reagent registration certificates, and obtained two registration certificates in November
2020.11 Completed the third batch of 16 product registration inspections, and completed the second batch of 6 product physical examinations
MORE
Added 15 new reagent items and research and development of CL-1000 automatic luminescence analyzer
2020.7 Received 30 million + Pre-A round of financing
2020.9 Obtained four reagent registration certificates, and obtained two registration certificates in November
2020.11 Completed the third batch of 16 product registration inspections, and completed the second batch of 6 product physical examinations
2019
2019
2022-03-03
2019.6 Approval of the instrument
2019.7 A total of 5 reagents obtained registration inspection reports
2019.12 Conversion of instruments and reagents
MORE
2019.6 Approval of the instrument
2019.7 A total of 5 reagents obtained registration inspection reports
2019.12 Conversion of instruments and reagents
2018
2018
2022-03-03
2018.5 Instrument submission registration, start reagent research and development
2018.9 Obtained the instrument CE certificate
2018.10 Obtained the instrument registration inspection report
2018.11 Complete the on-site physical examination of the instrument
MORE
2018.5 Instrument submission registration, start reagent research and development
2018.9 Obtained the instrument CE certificate
2018.10 Obtained the instrument registration inspection report
2018.11 Complete the on-site physical examination of the instrument
2017
2017
2022-03-03
In 2017, the development of luminescent product instruments started

2017.10 Obtained the joint angel investment of Beijing Qi Lun Tianyou and Shenzhen Kaiying Capital
MORE
In 2017, the development of luminescent product instruments started

2017.10 Obtained the joint angel investment of Beijing Qi Lun Tianyou and Shenzhen Kaiying Capital
Previous page
1
TIACHEN

Follow Tiachen

TIACHEN
TIACHEN
TIACHEN
  • Add: 301, Block A, Building #1, Phase 2, Gaoxinqi Industrial Zone, 1st Liuxian Road, Bao’an District, Shenzhen

  • Add:3rd Floor, Building B, Youlitong Technology Park, No. 56 Qingsong Road, Pingshan District, Shenzhen

  • service@tiachen.com.cn

© COPYRIGHT 2022 Shenzhen Tiachen Medical Technology Co., Ltd.. ALL RIGHTS RESERVED    粤ICP备19151424号   SEO

TIACHEN
TIACHEN

Follow Tiachen

  • Tel:0755-86713679

  • Add: 301, Block A, Building #1, Phase 2, Gaoxinqi Industrial Zone, 1st Liuxian Road, Bao’an District, Shenzhen

  • Add:3rd Floor, Building B, Youlitong Technology Park, No. 56 Qingsong Road, Pingshan District, Shenzhen

  • service@tiachen.com.cn

Copyright: Shenzhen Tiachen Medical Technology Co., Ltd.,  粤ICP备19151424号